Ann M. Hanly

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ann M. Hanly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vir Biotechnology, Inc. EVP & Chief Technology Officer Common Stock 118K $1.11M $9.45 24 Feb 2025 Direct
Vir Biotechnology, Inc. EVP & Chief Technology Officer Stock Option (Right to Buy) 65K $99.5K $1.53 22 Feb 2024 Direct

Insider Reports Filed by Ann M. Hanly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIR Vir Biotechnology, Inc. 24 Feb 2025 1 -$134K 4 25 Feb 2025 EVP & Chief Technology Officer
VIR Vir Biotechnology, Inc. 01 Apr 2024 1 -$27.3K 4 02 Apr 2024 EVP & Chief Technology Officer
VIR Vir Biotechnology, Inc. 22 Feb 2024 3 -$124K 4 26 Feb 2024 EVP & Chief Technology Officer
VIR Vir Biotechnology, Inc. 30 Mar 2023 1 -$59.8K 4 31 Mar 2023 Chief Technology Officer
VIR Vir Biotechnology, Inc. 22 Feb 2023 3 -$59.8K 4 24 Feb 2023 Chief Technology Officer
VIR Vir Biotechnology, Inc. 30 Mar 2022 1 -$68.9K 4 31 Mar 2022 Chief Technology Officer
VIR Vir Biotechnology, Inc. 22 Feb 2022 2 $0 4 24 Feb 2022 Chief Technology Officer
VIR Vir Biotechnology, Inc. 29 Nov 2021 1 $500 4 01 Dec 2021 Chief Technology Officer